This clinical study will be conducted in Pailin, where poor parasitological responses to artesunate have been documented. FHI took on the management of a village malaria worker programme in Pailin, previously developed by MSF, and have developed the clinical facility. Trials of artesunate-pyronaridine, coordinated by FHI are now taking place there.